5.525
전일 마감가:
$6.15
열려 있는:
$6.15
하루 거래량:
162.71K
Relative Volume:
1.04
시가총액:
$276.05M
수익:
$15.33M
순이익/손실:
$-40.19M
주가수익비율:
-3.1532
EPS:
-1.7522
순현금흐름:
-
1주 성능:
-4.74%
1개월 성능:
-25.54%
6개월 성능:
+17.30%
1년 성능:
+14.39%
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
명칭
Trisalus Life Sciences Inc
전화
415 336 8917
주소
6272 WEST 91ST AVENUE, WESTMINSTER
TLSI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TLSI
Trisalus Life Sciences Inc
|
5.525 | 307.28M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 개시 | Lake Street | Buy |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-11 | 개시 | ROTH MKM | Buy |
| 2024-10-25 | 개시 | Northland Capital | Outperform |
| 2024-09-16 | 개시 | Oppenheimer | Outperform |
| 2024-05-30 | 개시 | Canaccord Genuity | Buy |
모두보기
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
Published on: 2026-01-18 10:38:25 - baoquankhu1.vn
Rate Hike: Is TriSalus Life Sciences Inc stock a value trapRecession Risk & AI Driven Stock Price Forecasts - baoquankhu1.vn
TriSalus Life Sciences, Inc. (TLSI) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Does TriSalus Life Sciences Inc. have strong EBITDA marginsStock Correlation Metrics & AI-Based Insights for Consistent Profits - bollywoodhelpline.com
TriSalus Life Sciences reports 60% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Gap Down: Does TriSalus Life Sciences Inc have strong EBITDA marginsShort Setup & Consistent Profit Trading Strategies - baoquankhu1.vn
Oncology company TriSalus boosts sales in fourth quarter - BizWest
Jobs Data: Is TriSalus Life Sciences Inc Equity Warrant in a long term uptrendJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - baoquankhu1.vn
TriSalus Life Sciences reports 60% revenue growth in Q4 2025 - Investing.com
Cancer-focused medical tech firm’s sales jump 60% in latest quarter - Stock Titan
TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance - Bluefield Daily Telegraph
Is TriSalus Life Sciences Inc Equity Warrant in a long term uptrendDip Buying & High Conviction Trade Alerts - baoquankhu1.vn
What risks investors should watch in TriSalus Life Sciences Inc. Equity Warrant stockWeekly Trade Summary & Short-Term High Return Strategies - Улправда
TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Up 13.9% – Should You Buy? - Defense World
Can Sumeet Industries Limited (514211) Maintain Its ValuationEquity Performance Review & Use Our Sector Rotation Strategy for Gains - bollywoodhelpline.com
Trisalus Life Sciences CFO buys $33,900 in common stock - MSN
Is TriSalus Life Sciences Inc. stock vulnerable to regulatory risksJuly 2025 Big Picture & Community Verified Trade Signals - Улправда
How geopolitical risks impact CDP stockPortfolio Update Report & Consistent Profit Focused Trading Strategies - ulpravda.ru
Will National Research Corporation stock deliver shareholder valueGap Down & Expert Approved Momentum Ideas - ulpravda.ru
Is NeuroSense Therapeutics Ltd. stock resilient to inflationGlobal Markets & Weekly High Momentum Picks - ulpravda.ru
Will TriSalus Life Sciences Inc. Equity Warrant stock deliver long term returns2025 Short Interest & Consistent Profit Trading Strategies - Улправда
Is TriSalus Life Sciences Inc. Equity Warrant stock safe for conservative investorsJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - Улправда
Will TriSalus Life Sciences Inc. stock keep outperforming rivalsJuly 2025 Setups & Community Verified Swing Trade Signals - Улправда
Will TriSalus Life Sciences Inc. Equity Warrant stock maintain momentum in 2025 - Улправда
Aug Sentiment: Will TriSalus Life Sciences Inc. Equity Warrant stock maintain dividend yieldJuly 2025 Gainers & Weekly Consistent Profit Watchlists - Улправда
Will Bulten AB (publ) (3FB) stock return to pre crash levels2025 Dividend Review & Technical Entry and Exit Tips - ulpravda.ru
2026 world cup mexico quarterfinals playmakers pressing system expert tips breakdownMid Cap Growth Trends & Low Cost Portfolio Growth - ulpravda.ru
Analysts Spot Bullish Divergence in Oberoi Realty LimitedSector Performance Review & Double Digit Portfolio Growth - bollywoodhelpline.com
Why TriSalus Life Sciences Inc. stock remains resilient2026 world cup usa national team qualification goalkeepers possession football odds analysis expert opinion - Улправда
Expanding Indications and Diversified Revenue Base Support Buy Rating on TriSalus Life Sciences - TipRanks
TriSalus Life Sciences launches preferred stock exchange - MSN
Bullish Divergence Spotted in Vibrant Global Capital Limited MomentumRisk-Reward Ratio Analysis & Market Monitoring and Alerts - bollywoodhelpline.com
Finance Limited Stock Approaches Key Moving AverageCapital Gains Strategies & Superior Wealth Growth - bollywoodhelpline.com
Sathavahana Ispat Limited (526093) Announces Strategic ShiftLong-Term Investment Plans & Free Get Breakthrough Ideas - bollywoodhelpline.com
Epigral Limited Builds Base for Possible ReboundFundamental Stock Analysis & Low Cost Trading Tips - bollywoodhelpline.com
Will Sun Communities Inc. stock attract ESG investorsPortfolio Diversification Tips & Affordable Market Trading - bollywoodhelpline.com
Use hedged strategies (never naked short)Dividend Reinvestment Plans & Free Superior Stock Performance - bollywoodhelpline.com
Analysts’ Top Healthcare Picks: Assertio Therapeutics (ASRT), REPRO-MED Systems (KRMD) - The Globe and Mail
Portfolio rebalancing decisions can be guided by facts not emotionsStock Price Divergence & AI Alerts You Can Actually Trust - bollywoodhelpline.com
Is Harshdeep Hortico Limited (544105) a Good Long Term BetDividend Stability Analysis & Small Capital Gains - bollywoodhelpline.com
Energy Limited Matches Institutional Buying FilterInterest Rate Changes & Identify Breakout Stocks - bollywoodhelpline.com
Terumo (OTCMKTS:TRUMY) vs. TriSalus Life Sciences (NASDAQ:TLSI) Critical Survey - Defense World
Contrasting Stagezero Life Sciences (OTCMKTS:SZLSF) and TriSalus Life Sciences (NASDAQ:TLSI) - Defense World
Can Pramara Promotions Limited (PRAMARA) Maintain Its ValuationRelative Strength Index (RSI) & Weekly Consultation With Financial Pros - bollywoodhelpline.com
What analysts say about TriSalus Life Sciences Inc Equity Warrant stockResistance Breakout Alerts & Amplify Gains With Picks - earlytimes.in
Screener Results Flag Parag Milk Foods Limited as OversoldFlag and Pennant Patterns & Fast Growing Trading Plans - bollywoodhelpline.com
Trading Bots Trigger Alerts on Hasti Finance Limited ActivityInsider Selling Patterns & Affordable Investment Strategies - bollywoodhelpline.com
Previous dips into Fibs triggered strong buybacksGlobal Trade Effects & Superior Capital Growth - bollywoodhelpline.com
Krishna Defence and Allied Industries Limited Attempts Reversal From Key SupportChart Pattern Recognition & Low Entry Investment Plans - bollywoodhelpline.com
Praxis Home Retail Limited (PRAXIS) Expands into New MarketEarnings Season Recap & Outstanding Growth Stocks - bollywoodhelpline.com
Resistance Break Could Fuel Vippy Spinpro Limited RallyShort Selling Opportunities & Big Gains Small Investment - bollywoodhelpline.com
Trisalus Life Sciences Inc (TLSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Trisalus Life Sciences Inc 주식 (TLSI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
May 19 '25 |
Sale |
5.18 |
4,764 |
24,678 |
52,764 |
| Marshak Richard | Chief Commercial Officer |
May 19 '25 |
Sale |
5.18 |
6,597 |
34,172 |
69,101 |
| Stevens Jennifer | Chief Regulatory Officer |
May 19 '25 |
Sale |
5.18 |
8,704 |
45,087 |
77,640 |
| Young James Emmett | Chief Financial Officer |
Feb 05 '25 |
Buy |
5.65 |
6,000 |
33,900 |
30,000 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
자본화:
|
볼륨(24시간):